Robbins Farley LLC Amgen Inc Transaction History

Robbins Farley LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$229.03 - $291.01 $3,435 - $4,365	15 New	15 $3,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $10,613 - $12,435	-50 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $2,335 - $2,591	-10 Reduced 16.67%	50 $12,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $13,314 - $15,516	60 New	60 $15,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Robbins Farley LLC, based on Form 13F filings with the SEC.

Stay updated on Robbins Farley LLC with notifications on news.